SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Dreger P)
 

Search: WFRF:(Dreger P) > American Society of...

American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma

Munshi, Pashna N. (author)
MedStar Georgetown University Hospital
Hamadani, Mehdi (author)
Medical College of Wisconsin
Kumar, Ambuj (author)
University of South Florida
show more...
Dreger, Peter (author)
Heidelberg University
Friedberg, Jonathan W. (author)
University of Rochester
Dreyling, Martin (author)
University Hospital Munich
Kahl, Brad (author)
Washington University in St. Louis
Jerkeman, Mats (author)
Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lymfom - Klinisk forskning,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Onkologi övergripande,Institutionen för kliniska vetenskaper, Lund,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lymphoma - Clinical Research,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Oncology corporate,Department of Clinical Sciences, Lund,Skåne University Hospital
Kharfan-Dabaja, Mohamed A. (author)
Mayo Clinic Florida
Locke, Frederick L. (author)
H. Lee Moffitt Cancer Center & Research Institute
Shadman, Mazyar (author)
Fred Hutchinson Cancer Research Center
Hill, Brian T. (author)
Cleveland Clinic Taussig Cancer Center
Ahmed, Sairah (author)
University of Texas
Herrera, Alex F. (author)
City of Hope National Medical Center
Sauter, Craig S. (author)
Weill Cornell Medical College
Bachanova, Veronika (author)
University of Minnesota
Ghosh, Nilanjan (author)
Atrium Health Levine Cancer Institute
Lunning, Matthew (author)
University of Nebraska Medical Center
Kenkre, Vaishalee P. (author)
University of Wisconsin-Madison
Aljurf, Mahmoud (author)
King Faisal Specialist Hospital and Research Centre
Wang, Michael (author)
University of Texas
Maddocks, Kami J. (author)
Ohio State University
Leonard, John P. (author)
Weill Cornell Medicine
Kamdar, Manali (author)
University of Colorado
Phillips, Tycel (author)
University of Michigan Rogel Cancer Center
Cashen, Amanda F. (author)
Washington University in St. Louis
Inwards, David J. (author)
Mayo Clinic Minnesota
Sureda, Anna (author)
University of Barcelona
Cohen, Jonathon B. (author)
Emory University
Smith, Sonali M. (author)
University of Chicago
Carlo-Stella, Carmello (author)
Humanitas Research Hospital
Savani, Bipin (author)
Vanderbilt University
Robinson, Stephen P. (author)
NHS Foundation Trust
Fenske, Timothy S. (author)
Medical College of Wisconsin
show less...
 (creator_code:org_t)
Elsevier BV, 2021
2021
English 9 s.
In: Transplantation and cellular therapy. - : Elsevier BV. - 2666-6367. ; 27:9, s. 720-728
Related links:
http://dx.doi.org/10... (free)
show more...
https://doi.org/10.1...
https://lup.lub.lu.s...
https://doi.org/10.1...
show less...
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Autologous (auto-) and allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted treatment modalities in contemporary treatment algorithms for mantle cell lymphoma (MCL). Chimeric antigen receptor (CAR) T cell therapy recently received approval for MCL; however, its exact place and sequence in relation to HCT remain unclear. The American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and the European Society for Blood and Marrow Transplantation jointly convened an expert panel to formulate consensus recommendations for role, timing, and sequencing of auto-HCT, allo-HCT, and CAR T cell therapy for patients with newly diagnosed and relapsed/refractory (R/R) MCL. The RAND-modified Delphi method was used to generate consensus statements. Seventeen consensus statements were generated, with a few key statements as follows: in the first line setting, auto-HCT consolidation represents standard of care in eligible patients, whereas there is no clear role of allo-HCT or CAR T cell therapy outside of clinical trials. In the R/R setting, the preferential option is CAR T cell therapy, especially in patients with MCL failing or intolerant to at least one Bruton's tyrosine kinase inhibitor, while allo-HCT is recommended if CAR T cell therapy fails or is infeasible. Several recommendations were based on expert opinion, where the panel developed consensus statements for important real-world clinical scenarios to guide clinical practice. In the absence of contemporary evidence-based data, the panel found RAND-modified Delphi methodology effective in providing a formal framework for developing consensus recommendations for the timing and sequence of cellular therapies for MCL.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Keyword

Allogeneic transplantation
Autologous transplantation
CAR T cell
Cellular therapy
Consensus
Mantle cell lymphoma

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view